Kari L. Berg

Kari L. Berg has a diverse work experience in the pharmaceutical industry. Kari L. is currently working at Intercept Pharmaceuticals as a Territory Business Manager since 2023. Prior to that, they worked at Dynavax Technologies as a Senior Manager, Key Accounts from 2021 to 2023 and as a Regional Account Manager from 2020 to 2021. Kari L. also worked at Lundbeck as a Psychiatry Account Manager from 2019 to 2020, at Eisai US as an Oncology Sales Specialist from 2015 to 2018, at Cardinal Health as a Medical and Surgical Product Sales from 2011 to 2015, at Bristol-Myers Squibb as a Neuroscience Territory Business Manager from 2008 to 2009, at Takeda Pharmaceuticals as a Diabetes Specialty Sales from 2004 to 2008, and at Pfizer as a Pharmaceutical Sales from 2001 to 2004.

Kari L. Berg holds a Master of Science degree in Health Sciences from Minnesota State University, Mankato. Kari L. also has a Doctor of Philosophy degree in Teaching and Learning from the University of North Dakota. In addition, they completed their undergraduate studies in Biology/Biological Sciences at Mayville State University. Moreover, Kari obtained a certification as a Certified Health Education Specialist from the National Commission for Health Education Credentialing, Inc in April 2012.